entrectinib,
N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methyl-1-piperazinyl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide,
NMS-E628,
RXDX-101,
Entrectinib,
1108743-60-7,
RXDX-101,
NMS-E628,
Entrectinib (RXDX-101),
UNII-L5ORF0AN1I,
L5ORF0AN1I,
Benzamide, N-(5-((3,5-difluorophenyl)methyl)-1H-indazol-3-yl)-4-(4-methyl-1-piperazinyl)-2-((tetrahydro-2H-pyran-4-yl)amino)-,
Benzamide, N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methyl-1-piperazinyl)-2-[(tetrahydro-2H-pyran-4-yl)amino]-,
N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide,
Entrectinib [USAN:INN],
YMX,
Entrectinib, 95%,
entrectinib-rxdx-101,
Kinome_2659,
Entrectinib(rxdx-101),
Entrectinib (USAN/INN),
Entrectinib; NMS-E628,
GTPL8290,
SCHEMBL3512601,
CHEMBL1983268,
KS-00000TSK,
NMS-E-628,
HAYYBYPASCDWEQ-UHFFFAOYSA-N,
BCP16174,
EX-A2261,
MFCD28129099,
s7998,
ZINC43204146,
AKOS030632786,
DB11986,
SB17194,
NCGC00484067-01,
NCGC00484067-03,
AK547001,
DA-47850,
HY-12678,
N-(5-(3,5-Difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide,
B5859,
FT-0736318,
D10926,
S900006830,
N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide,
N-[5-(3,5-Difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide,
N-{5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl}-4-(4-methylpiperazin-1-yl)-2-[(oxan-4-yl)amino]benzamide,
N-{5-[(3,5-difluorophenyl)methyl]-3H-indazol-3-ylidene}-4-(4-methylpiperazin-1-yl)-2-[(oxan-4-yl)amino]benzamide,
Entrectinib [INN],
D0O0LS,
RXDX 101,
C31-H34-F2-N6-O2,
CS-4343,
A15801,
N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-((tetrahydro-2H-pyran-4-yl)amino)benzamide,
N-[5-(3,5-Difluorobenzyl)-1H-indazol-3-yl]-4-(4 methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)Benzamide,